person

Evanguelos X.

Country
France
Department
Urology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
141
Sites with multiple studies

Has run more than one trial at 141 of 318 partner sites.

Specializations

Prostate Cancer Research

The investigator specializes in treating high-risk and locally advanced prostate cancer, with particular focus on innovative therapeutic approaches. Their work extends to managing biochemically recurrent prostate cancer using hormone therapy combinations.

  • Surgical interventions for advanced cases
  • Androgen deprivation therapy optimization
  • PSA-based recurrence management

Their research encompasses perioperative treatments and novel therapeutic combinations for prostate cancer management.

Non-Muscle Invasive Bladder Cancer

The investigator focuses on treating high-risk non-muscle invasive bladder cancer, particularly in cases unresponsive to conventional therapies. They have expertise in managing BCG-unresponsive bladder cancer and exploring alternative treatment approaches.

  • Intravesical therapy development
  • Novel therapeutic combinations
  • Treatment strategies for BCG-naïve patients

Their work includes evaluation of new therapeutic options for patients ineligible for standard treatments.

Muscle Invasive Bladder Cancer

The investigator conducts research in muscle-invasive urothelial carcinoma treatment, with expertise in multimodal therapeutic approaches. Their work encompasses bladder-preserving strategies and combination treatments.

  • Chemoradiotherapy protocols
  • Immunotherapy combinations
  • Surgical intervention strategies

They explore innovative treatment combinations for optimal patient outcomes in advanced bladder cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.